North America Hemostasis Diagnostics Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 2,000.00$ 6,900.00

North America Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography

 

$ PRICE - $ 2,000.00$ 6,900.00
Region North America
Clear selection
Clear
$ PRICE - $ 2,000.00$ 6,900.00
FacebookTwitterLinkedinEmail

Report

Description

North America Hemostasis Diagnostics Market is expected to grow at a CAGR of x% during the forecast period 2022 to 2028. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market. North America Hemostasis Diagnostics Market report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user and region. This report studies North America Hemostasis Diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged.

North America Hemostasis Diagnostics Market

MARKET SUMMARY
-
x% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–x%
  • Largest Market– USA
  • Fastest Growing Market– Canada

North America Hemostasis Diagnostics Market

  • The report on North America Hemostasis Diagnostics Market gives historical, current, and future market sizes (US$ Mn) on the product type, test type, technology, end user and geography.
  • North America Hemostasis Diagnostics Market report gives comprehensive outlook across the region with special emphasis on key countries such as USA, Canada and Rest of North America Countries
Key Players
  • Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Abbott Laboratories
  • Alere Inc.
  • Nihon Kohden Corporation
Dynamics

North America Hemostasis Diagnostics Market

Increase in the prevalence of hemophilia disease in U.S. and Canada (according to Canadian Hemophilia Society, approximately 35,000 Canadians are having an inherited bleeding disorder gene), rise in number of surgeries, technological advancements in the hemostasis diagnostics such as accurate results in less time, and rise in R&D investment for novel tests and devices innovation are expected to boost the hemostasis diagnostics market


USA got significant share

North America Hemostasis Diagnostics Market

Geographically, North America hemostasis diagnostics market has been segmented into U.S. and Canada. U.S. hemostasis diagnostics market is projected to grow at a significant CAGR owing to increase in the prevalence of hemophilia disease. For instance, according to Centre for Disease Control and Prevention 2015, approximately 20,000 people are suffering from hemophilia in U.S., increase in the R&D activities for the development of newer tests, and FDA clearance for the newer diagnostics tests are anticipated to fuel the market. Canada hemostasis diagnostics market expected to grow at notable rate due to increase in the prevalence of hemophilia disease, rise in prevalence & incidence of various cardiovascular diseases and expansion of business by the market players in Canada are expected to propel the market. For instance, in February 2012, Roche collaborated with Technoclone to expand the reagent portfolio for coagulation diagnostics in US and Canada.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and start-up’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

North America Hemostasis Diagnostics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Abbott Laboratories
  • Alere Inc.
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Danaher Corporation
  • Instrumentation Laboratory
  • Grifols S.A
  • Beckman Coulter

Description

North America Hemostasis Diagnostics Market is expected to grow at a CAGR of x% during the forecast period 2022 to 2028. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market. North America Hemostasis Diagnostics Market report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user and region. This report studies North America Hemostasis Diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX